The fifth edition of the World Health Organization Classification of Haematolymphoid
Tumours (WHO‐HAEM5) is the product of an evidence‐based evolution of the revised fourth …

Abstract Purpose of Review This article summarizes the current state of knowledge of hairy
cell leukemia (HCL) regarding presentation, diagnosis, therapy, and monitoring, including …

Simple Summary Hairy cell leukemia (HCL) is a rare B cell neoplasm that accounts for 2% of
B-cell lymphomas. The diagnosis was based on the presence of abnormal lymphoid cells …

In understanding clonal evolution in cancer, whole genome sequencing (WGS) provides
unparalleled data that can be leveraged to derive tumor phylogenies. Specifically, estimates …

Simple Summary Classic hairy cell leukemia (HCL) is a rare, chronic B-cell malignancy with
long-term remissions after standard treatment with purine analogues introduced in the …

Methods Disease-specific patient records have been reviewed at each center, and all
patients requiring treatment who received frontline cladribine have been extrapolated …

Highlights●The genus Cordyceps is well known for producing numerous bioactive
compounds with emerging medicinal potentials.●Using integrated omics and systems …

Background Hairy cell leukemia (HCL) is a rare chronic B cell malignancy, characterized by
infiltration of bone marrow, blood and spleen by typical “hairy cells” that bear the …

Both characteristics and optimal treatment strategy for hairy cell leukemia-variant (HCL-v)
remain elusive due to its rarity. We retrospectively analyzed the clinical features of HCL-v …

Engineering immune cells to treat hematological malignancies has been a major focus of
research since the first resounding successes of CAR-T-cell therapies in B-ALL. Several …